TY - JOUR
T1 - Downregulation of NEDD9 by apigenin suppresses migration, invasion, and metastasis of colorectal cancer cells
AU - Dai, Jin
AU - Van Wie, Peter G.
AU - Fai, Leonard Yenwong
AU - Kim, Donghern
AU - Wang, Lei
AU - Poyil, Pratheeshkumar
AU - Luo, Jia
AU - Zhang, Zhuo
N1 - Publisher Copyright:
© 2016 Elsevier Inc.
PY - 2016/11/15
Y1 - 2016/11/15
N2 - Apigenin is a natural flavonoid which possesses multiple anti-cancer properties such as anti-proliferation, anti-inflammation, and anti-metastasis in many types of cancers including colorectal cancer. Neural precursor cell expressed developmentally downregulated 9 (NEDD9) is a multi-domain scaffolding protein of the Cas family which has been shown to correlate with cancer metastasis and progression. The present study investigates the role of NEDD9 in apigenin-inhibited cell migration, invasion, and metastasis of colorectal adenocarcinoma DLD1 and SW480 cells. The results show that knockdown of NEDD9 inhibited cell migration, invasion, and metastasis and that overexpression of NEDD9 promoted cell migration and invasion of DLD1 cells and SW4890 cells. Apigenin treatment attenuated NEDD9 expression at protein level, resulting in reduced phosphorylations of FAK, Src, and Akt, leading to inhibition on cell migration, invasion, and metastasis of both DLD1 and SW480 cells. The present study has demonstrated that apigenin inhibits cell migration, invasion, and metastasis through NEDD9/Src/Akt cascade in colorectal cancer cells. NEDD9 may function as a biomarker for evaluation of cancer aggressiveness and for selection of therapeutic drugs against cancer progression.
AB - Apigenin is a natural flavonoid which possesses multiple anti-cancer properties such as anti-proliferation, anti-inflammation, and anti-metastasis in many types of cancers including colorectal cancer. Neural precursor cell expressed developmentally downregulated 9 (NEDD9) is a multi-domain scaffolding protein of the Cas family which has been shown to correlate with cancer metastasis and progression. The present study investigates the role of NEDD9 in apigenin-inhibited cell migration, invasion, and metastasis of colorectal adenocarcinoma DLD1 and SW480 cells. The results show that knockdown of NEDD9 inhibited cell migration, invasion, and metastasis and that overexpression of NEDD9 promoted cell migration and invasion of DLD1 cells and SW4890 cells. Apigenin treatment attenuated NEDD9 expression at protein level, resulting in reduced phosphorylations of FAK, Src, and Akt, leading to inhibition on cell migration, invasion, and metastasis of both DLD1 and SW480 cells. The present study has demonstrated that apigenin inhibits cell migration, invasion, and metastasis through NEDD9/Src/Akt cascade in colorectal cancer cells. NEDD9 may function as a biomarker for evaluation of cancer aggressiveness and for selection of therapeutic drugs against cancer progression.
KW - Apigenin
KW - Colorectal cancer
KW - Invasion
KW - Metastasis
KW - Migration
KW - NEDD9
UR - http://www.scopus.com/inward/record.url?scp=84992377644&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84992377644&partnerID=8YFLogxK
U2 - 10.1016/j.taap.2016.09.016
DO - 10.1016/j.taap.2016.09.016
M3 - Article
C2 - 27664007
AN - SCOPUS:84992377644
SN - 0041-008X
VL - 311
SP - 106
EP - 112
JO - Toxicology and Applied Pharmacology
JF - Toxicology and Applied Pharmacology
ER -